Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v7-EN
Language French English
Date Updated 2017-10-31 2017-09-22
Drug Identification Number 02242838 02242838
Brand name APO-LITHIUM CARBONATE APO-LITHIUM CARBONATE
Common or Proper name LITHIUM CARBONATE LITHIUM CARBONATE
Company Name APOTEX INC APOTEX INC
Ingredients LITHIUM CARBONATE LITHIUM CARBONATE
Strength(s) 300MG 300MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N05AN N05AN
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-09-08 2017-09-08
Actual start date 2017-08-15 2017-08-15
Estimated end date 2017-11-06 2017-11-20
Actual end date 2017-10-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments APO-LITHIUM CARBONATE 300 MG CAP 1000BTL available APO-LITHIUM CARBONATE 300 MG CAP 1000BTL available
Health Canada comments